The transformation to value-based medical care, artificial intelligence (AI) and machine learning, and the rise of private insurance models is predicted to have the most substantial adjustments to how the healthcare industry functions, according to Forbes.
Forbes has published predictions on the evolution to the healthcare industry for the last 10 years.
Healthcare organizations have their plates full, juggling the latest and greatest offerings and cutting-edge tools, all while figuring out budgets to support the advanced tech tools and procuring staff with the capacity to oversee them. One of these trending tools on every administrator’s mind is preparing for and implementing Artificial Intelligence (AI).
Read any article or watch a news clip about the subject, and there are common themes that AI is projected to bring to the table — you’ll hear words like:
The bottom line is that AI is seen as a benefit to the patient, first and foremost. With continuous connectivity and the capacity to learn, AI would have the ability to improve clinical efficiency by collecting, aggregating, and analyzing patient data —the results of this learning can then be used to improve patient adherence, engagement, and to proactively advise on next steps. AI in a clinical setting would prove its effectiveness as it begins to transform the healthcare system into one more focused on preventative care as opposed to reactionary care.
In a survey conducted by Intel and Convergys Analytics, half of the participating professionals reported that widespread adoption of AI is imminent — predicting that it will be common practice within five years.
Nearly 20% believe that AI will be completely adopted in less than two years.
The poll found that 37% of respondents are already using artificial intelligence within their organizations in some capacity.
The three objectives include:
It is evident that most recent healthcare reform initiatives by the government regarding healthcare policy and funding, is fueled by the Triple Aim.
The three aims are not a new concept per se, but it wasn’t until government mandated healthcare reform, i.e Obamacare, that the Triple Aim became a sought-after goal for health organizations.
Following these three Triple Aim objectives enables healthcare organizations to recognize and solve problems such as poor coordination of care and excessive use of medical services. It also encourages organizations to focus attention on and redirect resources to action that produce the most considerable impact on health.
The United States healthcare system is the most costly in the world, accounting for 17% of the gross domestic product with estimates that percentage will grow to 19.9% of GDP by 2022.
It is a safe assumption to make that medical equipment buyers want to save money. In 2018, now more than ever, hospitals, ASCs, and other healthcare institutions are under tremendous pressure to cut costs. But, many buyers do not necessarily think about Section 179 when shopping for equipment.
The Section 179 deduction is actually not a complicated tax code and is surprisingly a lot simpler than most realize. The IRS tax code, Section 179, permits businesses to subtract the full purchase price of qualifying equipment purchased or financed during the tax year. In other words, if you buy a piece of qualifying equipment, you can deduct the full purchase price from your gross income. It’s an incentive created by the U.S. government to encourage businesses to buy equipment and reinvest in growing their business.
Earlier this month, we looked into the topic of healthcare pricing transparency, and discussed why its relevant.
Today we dive into how pricing transparency affects our healthcare decisions and costs.
The average consumer, consciously or subconsciously, price shops on a daily basis — checking out which gas station has the cheapest price per gallon, which grocery store has the most affordable produce, and which Amazon wholesaler has the cheapest gadget.
But when it comes to our healthcare, that’s an entirely different ballgame.
The unfortunate truth is that consumers in the United States do not necessarily know the cost that they pay for healthcare because those financial implications by insurers and providers have historically been kept under wraps.
Price transparency is the ability for consumers to access provider-specific information on the price of healthcare services – including out-of-pocket costs − regardless of the setting in which they are delivered.
But healthcare does not operate like other industries – consumers do not necessarily have access to the price of services.
Costs for the same exact medical service can vary significantly from provider to provider; it is challenging for consumers to ascertain information in order to compare providers based on two important factors: price and quality.
Making insights on healthcare prices and quality obtainable will help consumers compare costs, choose physicians who truly have high value, as well as plan for the financial implications. This will also support policymakers to hold healthcare providers accountable for creating appropriate prices.
Even though the healthcare industry has been slower to embrace Internet of Things than other industries, the Internet of Medical Things (IoMT) is positioned to reshape how we keep people safe and healthy, particularly as solutions to lower healthcare costs is on the rise.
Allied Market Research predicts that the IoT healthcare market will reach $136.8 billion worldwide by 2021. There are over 3 million medical devices in circulation that are connected to and monitor patients to influence healthcare decisions.
Wearable devices and the decreasing cost to produce sensor technology are largely responsible for this impressive growth. Also, chronic diseases are on the rise, so advanced treatment options and reducing healthcare expenditures makes it even more alluring to utilize newer innovations.